Monographie - Amphotericin B lipid complex

Son güncelleme :
08/05/2024

Amphotericin B lipid complex

Kimyasal yapı

Ticari isim

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Abelcet

Almanya, Amerika Birleşik Devletleri, Arjantin, Avustralya, Avusturya, Belçika, Brezilya, Büyük Britanya, Danimarka, Finlandiya, Fransa, Hollanda, İrlanda, İspanya, İsveç, İtalya, Kanada, Lüksemburg, Macaristan, Malezya, Meksika, Norveç, Peru, Portekiz, Romanya, Yunanistan

Kaynaklar : Amphotericin B lipid complex

	Tip	Yayın
1510	Kitap	AHFS Formulary service 2000 Bethesda - 3546 p
2247	Dergi	Chan P, Heatherly K, Kupiec T.C, Trissel L.A. Compatibility of caspofungin acetate injection with other drugs during simulated Y-site coadministration. Int J Pharm Compound 2008 ; 12, 3: 276-278.
2262	Dergi	Brammer MK, Chan P, Heatherly K, Trusley C, Kupiec TC, Trissel LA, Psathas PA, Gilmor T, Schaufelberger D. Compatibility of doripenem with other drugs during simulated Y-site administratioN Am J Health-Syst Pharm 2008 ; 65: 1261-1265.
3254	Dergi	Housman S.T, Tessier P.R, Nicolau D.P, Kuti J.L. Physical compatibility of telavancin hydrochloride with select i.v. drugs during simulated Y-site administration Am J Health-Syst Pharm 2011 ; 68: 2265-2270.
3332	Laboratuar	Tigecycline (Tigacyl®) - Summary of Product characteristics Pfizer 2012
3644	Laboratuar	Calcium gluconate® - Summary of Product Characteristics Hameln Pharmaceuticals 2010
3828	Afiş	Thabit A.K, Hamada Y, Nicolau D.P. Ceftozolane/tazobactam physical compatibility during simulated Y-site administration. ASHP Midyear 2015
3829	Afiş	So W, Kim L, Thabit A.K, Nicolau D.P, Kuti J.L. Compatibility of isavunazonium sulfate during simulated Y-site administration. ASHP Midyear 2015
4055	Dergi	Monogue M, Almarzoky Abuhussain S, Kuti J, Nicolau D. Physical compatibility of fosfomycin for injection with select i.v. drugs during simulated Y-site administration. Am J Health-Syst Pharm 2018 , 75, 1:36-44

Mentions Légales